Bradykinin, a 9 aa peptide, is generated in pathophysiologic conditions such as inflammation, trauma, burns, shock, and allergy. Two types of G-protein coupled receptors have been found which bind bradykinin and mediate responses to these pathophysiologic conditions. The protein encoded by this gene is one of these receptors and is synthesized de novo following tissue injury. Receptor binding leads to an increase in the cytosolic calcium ion concentration, ultimately resulting in chronic and acute inflammatory responses. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].
Liu, Liu, Feng, Xiao: "Kinin B1 receptor as a novel, prognostic progression biomarker for carotid atherosclerotic plaques." in: Molecular medicine reports, Vol. 16, Issue 6, pp. 8930-8936, (2018) (PubMed).
Wu, Roks, Leijten, Garrelds, Musterd-Bhaggoe, van den Bogaerdt, de Maat, Simoons, Danser, Oeseburg: "Genetic variation and gender determine bradykinin type 1 receptor responses in human tissue: implications for the ACE-inhibitor-induced effects in patients with coronary artery disease." in: Clinical science (London, England : 1979), Vol. 126, Issue 6, pp. 441-9, (2014) (PubMed).
Gruber, Hoelscher, Ingram, Hanley: "Genome-wide analysis of pain-, nerve- and neurotrophin -related gene expression in the degenerating human annulus." in: Molecular pain, Vol. 8, pp. 63, (2012) (PubMed).
Bengtson, Eddleston, Christiansen, Zuraw: "Double-stranded RNA increases kinin B1 receptor expression and function in human airway epithelial cells." in: International immunopharmacology, Vol. 7, Issue 14, pp. 1880-7, (2007) (PubMed).